At NINGBO INNO PHARMCHEM CO.,LTD., we continuously seek to highlight compounds with significant therapeutic potential. Nastorazepide (Z-360), a selective CCK-2 receptor antagonist, is one such molecule, demonstrating not only anti-proliferative effects in cancers like pancreatic cancer but also promising activity in other critical areas of patient care: metastasis inhibition and pain management.

Cancer metastasis, the spread of cancer from its primary site to other parts of the body, is a major cause of cancer-related mortality. Preliminary research suggests that Nastorazepide may play a role in inhibiting this process, specifically in colorectal cancer liver metastasis. By targeting the CCK-2 receptor, which can be involved in cell adhesion and migration, Nastorazepide could offer a novel approach to limiting cancer spread. This aspect of its action is particularly exciting as it addresses a critical unmet need in improving survival rates for many cancer patients.

Furthermore, pain management is an essential component of comprehensive cancer care. Patients suffering from advanced stages of cancer often experience severe pain that significantly impacts their quality of life. Nastorazepide has shown potential in providing relief from such pain. While the exact mechanisms by which it alleviates pain are still under investigation, its interaction with the CCK-2 receptor, which is known to be involved in pain signaling pathways, suggests a plausible therapeutic link. This dual action—combating cancer progression and managing symptoms—underscores Nastorazepide's multifaceted therapeutic value.

NINGBO INNO PHARMCHEM CO.,LTD. is proud to supply high-quality Nastorazepide to researchers exploring these groundbreaking applications. Our commitment ensures that the scientific community has access to a reliable source of this compound for investigating its anti-metastatic and analgesic properties. As research continues, Nastorazepide is poised to become an increasingly important tool in the fight against cancer, offering hope for improved patient outcomes through advanced therapeutic strategies.